Bing Du

5.3k citations
106 papers · 3.0k · 2 hit papers · h-index 32

Impact in

  • Physiology top 1%
    • Adenosine and Purinergic Signaling
  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immune cells in cancer

Papers in

    • Immune Cell Function and Interaction 11
    • Immune cells in cancer 7
    • Immune Response and Inflammation 6
    • interferon and immune responses 5
    • Adenosine and Purinergic Signaling 14

Bing Du

101 papers receiving 3.0k citations

Bing Du's Hit Papers

CAR-T therapy in solid tumors 2025 · 111 citations
1110+2+4Years since publication100200300

Peers

Bing Du
Comparison fields: 5 of 132
  • Physiology 300
  • Immunology 527
  • Infectious Diseases 451
  • Oncology 518
  • Molecular Biology 1.1k
Replace Fengyi Wan with:
Fengyi Wan United States
Stephen Hatfield United States
Srinivasa Reddy Bonam India
Cristina Bonorino Brazil
Zhongyi Cheng China
Li Zhou China
Sunna Hauschildt Germany
Laura Masuelli Italy
Hang Thi Thu Nguyen United States
Klaas Poelstra Netherlands
Bing Du relative to Fengyi Wan United States Fengyi Wan's profile →
Citations per field
00.5×1.5×2×2.3×
Fengyi Wan · 1×
Citations per year

Countries citing papers authored by Bing Du

Since Specialization
Citations

This map shows the geographic impact of Bing Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Du more than expected).

Fields of papers citing papers by Bing Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Du. The network helps show where Bing Du may publish in the future.

Co-authors

The 25 scholars most cited alongside Bing Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bing Du Line = papers co-authored together Bing Du links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay
Hit paper breakdown →
2020392
2 2018137
3
CAR-T therapy in solid tumors
Hit paper breakdown →
2025111
4 2012111
5 201183
6 202083
7 201179
8 200878
9 201077
10 202076
11 201071
12 202069
13 201763
14 201060
15 200860
16 201458
17 202355
18 201452
19 202252
20 201547

About Bing Du

Bing Du is a scholar working on Immunology, Physiology, Oncology, Molecular Biology and Cancer Research, having authored 106 papers that have together received 3.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Adenosine and Purinergic Signaling (14 papers), Immune Cell Function and Interaction (11 papers), Immune cells in cancer (7 papers), Immune Response and Inflammation (6 papers), interferon and immune responses (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). The work is most often cited by research in Physiology (300 citations), Immunology (527 citations), Infectious Diseases (451 citations), Oncology (518 citations) and Molecular Biology (1.1k citations). Bing Du has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Min Qian, Mingyao Liu, Hua Ren, Juliang Qin, Binghe Tan, Honghui Han, Jing Yuan, Guanhua Xue, Chao Yan and Ziqiang Wang. Their work appears in journals such as The Journal of Immunology, Microbiology Spectrum, Science China Life Sciences, Frontiers in Immunology and Advanced Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact